PubMed

Generalizability of FDA-Approved AI-Enabled Medical Devices for Clinical Use.

PMID: 40305017 · 2025-04-01

D, a, n, i, e, l, , W, i, n, d, e, c, k, e, r, ;, , G, i, o, v, a, n, n, i, , B, a, j, ;, , I, s, a, a, c, , S, h, i, r, i, ;, , P, o, o, y, a, , M, o, h, a, m, m, a, d, i, , K, a, z, a, j, ;, , J, o, h, a, n, n, e, s, , K, a, e, s, m, a, c, h, e, r, ;, , C, h, r, i, s, t, o, p, h, , G, r, ä, n, i, ;, , G, e, o, r, g, e, , C, , M, , S, i, o, n, t, i, s

학술지JAMA network open

연도2025-04-01

PMID40305017

초록

The primary objective of any newly developed medical device using artificial intelligence (AI) is to ensure its safe and effective use in broader clinical practice. To evaluate key characteristics of AI-enabled medical devices approved by the US Food and Drug Administration (FDA) that are relevant to their clinical generalizability and are reported in the public domain. This cross-sectional study collected information on all AI-enabled medical devices that received FDA approval and were listed o

공식 출처

PubMed에서 보기 →

데이터는 PubMed / NCBI에서 제공됩니다. 전문과 최신 정보는 반드시 공식 기록을 확인하세요.